Prognostication and monitoring of mesothelioma using biomarkers: a systematic review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc201722.pdf
Reference58 articles.
1. Abakay O, Tanrikulu AC, Palanci Y, Abakay A (2014) The value of inflammatory parameters in the prognosis of malignant mesothelioma. J Int Med Res 42 (2): 554–565.
2. Altman DG (2001) Systematic reviews of evaluations of prognostic variables. BMJ 323 (7306): 224–228.
3. Anborgh PH, Wilson SM, Tuck AB, Winquist E, Schmidt N, Hart R, Kon S, Maeda M, Uede T, Stitt LW, Chambers AF (2009) New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs. Clin Chem 55 (5): 895–903.
4. Armato SG 3rd, Ogarek JL, Starkey A, Vogelzang NJ, Kindler HL, Kocherginsky M, MacMahon H (2006) Variability in mesothelioma tumor response classification. AJR Am J Roentgenol 186 (4): 1000–1006.
5. Arnold DT, Hooper CE, Morley A, White P, Lyburn ID, Searle J, Darby M, Hall T, Hall D, Rahman NM, De Winton E, Clive A, Masani V, Dangoor A, Guglani S, Jankowska P, Lowndes SA, Harvey JE, Braybrooke JP, Maskell NA (2015) The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial. Br J Cancer 112 (7): 1183–1189.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosis of Pleural Mesothelioma: Is Everything Solved at the Present Time?;Current Oncology;2024-08-27
2. Recent Advances in Mesothelioma;Current Pulmonology Reports;2024-05-23
3. The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma;Journal of Thoracic Oncology;2023-12
4. Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers;Journal of Clinical Medicine;2023-11-09
5. Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers;Cancer Biomarkers;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3